Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Cantor Fitzgerald
US Army
Healthtrust
Queensland Health
Boehringer Ingelheim
Daiichi Sankyo
Julphar
Fuji

Generated: June 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020121

« Back to Dashboard

NDA 020121 describes FLONASE, which is a drug marketed by Glaxosmithkline and Glaxosmithkline Cons and is included in three NDAs. There are eight patents protecting this drug. Additional details are available on the FLONASE profile page.

The generic ingredient in FLONASE is fluticasone furoate. There are twenty-six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the fluticasone furoate profile page.
Summary for 020121
Tradename:FLONASE
Applicant:Glaxosmithkline
Ingredient:fluticasone propionate
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Respiratory Tract Agents
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SPRAY, METERED;NASALStrength0.05MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Oct 19, 1994TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Dow
Farmers Insurance
Moodys
QuintilesIMS
Fuji
Teva
US Army
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.